Technical Articles
protein degradation
Why Biotinylated CRBN/DDB1 Became a Tool Position on Degradation-Drug Platforms
Molecular-glue and PROTAC platforms converge on CRBN-DDB1 engagement assays. This article traces the translational narrative behind the standardized tool.
View details
- Drug Research
- biotinylated CRBN DDB1
- molecular glue
- PROTAC
- protein degradation
- thalidomide
- standardization
- UA080262
How Biotinylated CRBN/DDB1 Participates in Protein Degradation: The CRL4 Complex and Molecular-Glue Mechanism
The CRL4 complex recruits substrates through CRBN-DDB1, and molecular glues reshape this interface. This article maps the degradation mechanism end to end.
View details
- Drug Research
- biotinylated CRBN DDB1
- CRL4 E3 ligase
- molecular glue
- PROTAC
- Avi Tag
- protein degradation
- UA080262
Application of KRAS G12C/CRBN PROTAC Kit Based on TR-FRET Technology in Targeted Protein Degradation Research
KRAS activating mutations are detectable in 25% to 30% of non-squamous non-small cell lung cancers, representing the most common genetic driver event in this cancer type. The Ras protein family includes three subtypes: KRAS, HRAS, and NRAS, with KRAS mutations accounting for 85% of Ras-driven cancers.
View details
- Drug Research
- TR-FRET Technology
- KRAS G12C/CRBN
- Protein Degradation
Application of VCB Complex Ligand Screening Kit Based on TR-FRET Technology in Targeted Protein Degradation Research
The VHL protein serves as the substrate recognition receptor of the Cullin 2 RING E3 ubiquitin ligase complex, forming the VCB complex together with Elongin B and Elongin C. This complex plays a critical role in cellular hypoxia response and protein homeostasis maintenance.
View details
- Drug Research
- TR-FRET Technology
- VCB (VHL Complex)
- Protein Degradation
Cathepsin F His Tag Protein: A Key Tool for Structural and Functional Research
Cathepsin F is an important member of the lysosomal cysteine protease family and plays a crucial role in protein degradation and cellular metabolism.
View details
- Metabolism
- Cathepsin F His Tag protein
- Protein degradation
- Cellular metabolism
Advances in Novel TCR Therapies Targeting KRAS G12V Mutation and Prospects for Protein Degradation Strategies
The KRAS gene is one of the most commonly mutated driver genes in various solid tumors, with the G12V mutation being the second most frequent subtype at codon 12 after G12D, frequently occurring in malignancies such as pancreatic cancer and colorectal cancer.
View details
- Cancer
- KRAS[G12V]/CRBN PROTAC Kit
- Solid tumor
- Protein degradation
Epidemiological Characteristics of KRAS G12C Mutations in Chinese Pan-Cancer and Novel Targeted Protein Degradation Therapeutic Strategies
The RAS gene family is the most common oncogene in human cancers, encoding proteins that act as critical molecular switches regulating cell proliferation and survival signaling pathways.
View details
- Cancer
- KRAS[G12C]/CRBN PROTAC Kit
- Oncogene
- Protein degradation
BCL-XL/CRBN PROTAC Kit: A Standardized Tool for Advancing Tumor-Selective Protein Degradation Therapy Development
Proteolysis Targeting Chimeras (PROTAC) is a revolutionary drug development platform that harnesses the cell's own ubiquitin-proteasome system to selectively degrade disease-causing proteins.
View details
- Cancer
- BCL-XL/CRBN PROTAC Kit
- Tumor
- Protein degradation
Targeting BCL6 Protein Degradation: From Key Transcription Factor to Novel Therapeutic Strategies
B-cell lymphoma 6 protein (BCL6) is a critical transcriptional repressor whose function plays a decisive role in the development of follicular helper T cells (Tfh).
View details
- Cancer
- Protein degradation
- BCL6/CRBN PROTAC Kit
- B cell lymphoma 6 protein
The role of CRBN ligands in targeted protein degradation technology and research progress in novel ligand development
Among various E3 ligases, Cereblon (CRBN) stands out as a central recruitment platform for targeted degrader design due to its unique advantages.
View details
- Drug Research
- CRBN Ligand Screening Assay Kit
- Protein degradation
- Ligand development
- 1
- 2















